
Atalanta Therapeutics
About
Atalanta Therapeutics is a biotechnology company developing treatments for intractable diseases of the central nervous system using RNA interference. Atalanta’s unique platform of divalent small interfering RNA (di-siRNA) enables durable, selective gene silencing throughout the brain and spinal cord. Atalanta is advancing a wholly owned pipeline of disease-modifying programs for Huntington’s disease, genetic epilepsy, severe chronic pain, and other neurological diseases in addition to partnered programs as part of a strategic collaboration with Genentech. We were founded by Anastasia Khvorova, Ph.D., Craig Mello, Ph.D., and Neil Aronin, M.D. of the RNA Therapeutics Institute at the University of Massachusetts Medical School. Atalanta is headquartered in Boston, Mass.
US
51 Sleeper Street, Boston, MA
02210
Privately Held
40
Biotechnology Research
Top Decision Makers · 1
Member Board of Directors
Douglas Pagan
United States
******@***.com
Phone
(**) *** ****
Find Any Email,
Find Any Phone Number
What LeadContact does well
Find anyone's verified emails, phone numbers and decision makers with 98% accuracy.
Find Emails
Access verified, up-to-date emails — instantly.
120M+ emails found for users

Find Phone Numbers
Cross-validated phone data from multiple top sources.
60M+ phones delivered

Find Decision Makers
Quickly find decision-makers by job title — in any company.
270M+ DMs identified

More Accurate. Less Cost.
Find contact in 1 tool with 98% accuracy rate
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.

